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Abstract
 
Celiac disease is caused by a selective lack of T cell tolerance for gluten. It is known that the en-
zyme tissue transglutaminase (tTG) is involved in the generation of T cell stimulatory gluten pep-
tides through deamidation of glutamine, the most abundant amino acid in gluten. Only particular
glutamine residues, however, are modified by tTG. Here we provide evidence that the spacing
between glutamine and proline, the second most abundant amino acid in gluten, plays an essen-
tial role in the specificity of deamidation. On the basis of this, algorithms were designed and used
to successfully predict novel T cell stimulatory peptides in gluten. Strikingly, these algorithms
identified many similar peptides in the gluten-like hordeins from barley and secalins from rye but
not in the avenins from oats. The avenins contain significantly lower percentages of proline resi-
dues, which offers a likely explanation for the lack of toxicity of oats. Thus, the unique amino
acid composition of gluten and related proteins in barley and rye favors the generation of toxic T
cell stimulatory gluten peptides by tTG. This provides a rationale for the observation that celiac
disease patients are intolerant to these cereal proteins but not to other common food proteins.
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Introduction
 
Celiac disease (CD) is a permanent intolerance to gluten
(1). Gluten is a complex mixture of storage proteins found
in wheat. Similar proteins are present in other grains like
barley, rye, and oats. Typical disease symptoms include
chronic diarrhea, fatigue, and failure to thrive. These
symptoms are associated with a lesion in the upper small in-
testine, characterized by a (sub) total villous atrophy, an
increased number of intraepithelial lymphocytes, and a
chronic inflammatory response of the lamina propria lym-
phocytes (1). A strong indication for CD is the presence of
antibodies specific for the enzyme tissue transglutaminase
(tTG) in patients (2). Moreover, recent studies demon-
strated the involvement of this enzyme in the generation of
T cell stimulatory peptides (3, 4). CD is strongly associated
with HLA-DQ2 (A1
 
*
 
0501, B1
 
*
 
0201) and HLA-DQ8
(A1
 
*
 
0301, B1
 
*
 
0302) (5). In addition, HLA-DQ2 and/or
HLA-DQ8 restricted, gluten-specific CD4
 
 
 
 T lympho-
cytes can be isolated from small intestinal biopsies of CD
patients, and these are thought to cause disease (6, 7). The
peptide-binding motif of HLA-DQ2 and -DQ8 predicts a
preference for negative charges at anchor positions in the
bound peptides (8–10). However, gluten molecules con-
tain few negative charges. This discrepancy was solved by
the finding that tTG can convert glutamine residues into
glutamic acid (a process termed deamidation), and thus in-
troduces negative charges in gluten peptides. Indeed it was
found that tTG is required for, or enhances the gluten-spe-
cific response of T cell clones and T cell lines derived from
the majority of CD patients (3, 4, 11, 12). Considering the
abundance of glutamine residues in gluten (
 
 
 
30–40%) tTG
has many potential target sites in gluten. Mass spectral anal-
ysis of the deamidated T cell stimulatory gluten peptides,
however, showed a highly restricted pattern of deamidation
(3, 4) that often coincides with the positions where nega-
tive charges are preferred in the HLA-binding motif, thus
favoring the binding of gluten peptides to HLA-DQ2 and/
or –DQ8. The specificity of gluten deamidation by tTG,
therefore, is a crucial factor in the generation of toxic glu-
ten peptides but it is not known why only particular
glutamine residues are targeted by tTG. This has been in-
vestigated in this study.
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Materials and Methods
 
Peptides and tTG Treatment.
 
Peptides were synthesized by
standard Fmoc chemistry on a multiple peptide synthesizer (Syr-
oII, MultiSynTech GmbH). Integrity of synthetic peptides was
checked by rpHPLC and mass spectrometry. tTG treatment was
performed by incubating the peptides (500 
 
 
 
g/ml) with the en-
zyme (100 
 
 
 
g/ml, T-5398; Sigma-Aldrich) at 37
 
 
 
C for 4 h min-
imum, in 50 mM triethylamine-acetate, pH 6.5, 2 mM CaCl
 
2
 
.
Throughout the manuscript the one letter code for amino acids
is used.
 
Mass Spectrometry.
 
Electrospray ionization mass spectrome-
try was performed on the synthetic gluten peptides before and
after tTG treatment, using a Q-TOF hybrid mass spectrometer
(Micromass). Precursor ions were selected with the quadruple
window set to 3 Da and fragments were collected with high effi-
ciency with the orthogonal time of flight mass spectrometer.
The collision gas applied was argon (pressure 4 
 
 
 
 10
 
 
 
5
 
 mbar)
and the collision voltage 
 
 
 
30 V. Deamidation of glutamine resi-
dues in synthetic gluten peptides was determined by mass spec-
trometric analysis as described previously (4). Deamidation of a
glutamine residue results in an increase of 1 Da. These conver-
sions were assigned to particular glutamine residues by compari-
son of the fragmentation spectra of tTG treated and nontreated
peptides (4).
 
Database Searching.
 
The program PeptideSearch was used for
pattern searches (13). The patterns were composed on the basis of
the newly identified specificity of tTG in combination with the
previously identified HLA-DQ2 peptide-binding motif (8, 9).
For database searching selected subsets of gluten, hordein, secalin,
and avenin proteins were compiled from the Swiss Prot databank,
SPTREMBL and PIR.
 
T Cell Clones and T Cell Lines.
 
Gluten-specific T cell lines
were generated from small intestinal biopsies of CD patients as de-
scribed previously (4, 7, 14). All patients gave informed consent to
the study, which was approved by the hospital ethics committee.
 
T Cell Proliferation Assays.
 
Proliferation assays were performed
in duplicate in 150 
 
 
 
l RPMI 1640 (GIBCO BRL) supplemented
with 10% human serum in 96-well, flat-bottomed plates (Falcon)
using 10
 
4
 
 T cells stimulated with 10
 
5
 
 irradiated PBMCs (3,000 rad)
in the presence or absence of antigen (1–10 
 
 
 
g/ml). After 48 h at
37
 
 
 
C, cultures were pulsed with 0.5 
 
 
 
Ci of 
 
3
 
[H]thymidine and
harvested 18 h thereafter as described previously (7).
 
Results
 
The Specificity of tTG.
 
Previously we have characterized
an HLA-DQ8–restricted, T cell stimulatory gliadin peptide
(4, 7). In the core of this gliadin peptide (sequence
PSGQ
 
208
 
GSFQPSQQ
 
216
 
NPQA) the Q
 
208
 
 and Q
 
216
 
 are
deamidated by tTG, whereas positions Q
 
212
 
, Q
 
215
 
, and Q
 
219
 
are not (4). Preliminary studies indicated that the nature of
COOH-terminal flanking amino acids influenced deamida-
tion of glutamine residues (data not shown). We have now
investigated this systematically by analyzing the deamida-
tion in amino acid substitution analogs of a shorter version
of the gliadin peptide (sequence: PSGQ
 
208
 
GSFQPSQQ
 
216
 
N).
In this peptide only the Q
 
208
 
 is deamidated by tTG treat-
ment (Fig. 1 A). Mass spectrometric analysis demonstrated
that at only two positions in the peptide substitutions had
effect on deamidation of Q
 
208
 
 (Fig. 1 A, and data not shown).
First, the replacement of Q
 
209
 
 by a P abolished deamidation
 
of Q
 
208
 
. Second, several amino acid substitutions at F
 
211
 
 had
a strong negative effect on deamidation of Q
 
208
 
, in particu-
lar replacements of F
 
211
 
 for amino acids with significantly
smaller or charged side chains or replacement by proline
(Fig. 1 A).
Next, we performed a similar analysis to determine the
influence of amino acid substitutions on the deamidation of
Q
 
216
 
 in a longer version of the peptide (Fig. 1 A). The re-
sults demonstrate that the substitution of N
 
217
 
 with a P
abolishes deamidation of Q
 
216
 
, a finding that underscores
the observation that in a QP sequence the Q is not a target
for tTG. Moreover, the substitution of Q
 
219
 
 with a P had a
negative effect on deamidation of Q
 
216
 
, confirming the
negative influence of the P in the sequence QXXP (X
stands for any amino acid). Other amino acid substitutions
at Q
 
216
 
 
 
3, however, had no effect on deamidation of Q
 
216
 
,
a result that is in contrast to the strong influence of amino
acid substitutions at position Q
 
208
 
 
 
3 on deamidation of
Q
 
208
 
. A marked difference between the sequence Q
 
208
 
GSF
and Q
 
216
 
NPQ is the presence of a P in the latter sequence
at Q
 
 
 
2 suggesting that in the sequence QXPX the Q is a
good target for deamidation and the nature of the amino
acid at Q
 
 
 
3 is much less important (see below).
Together the results indicate that in the sequences QP
and QXXP the Q is not a target for tTG. In contrast the
sequences QXP, QXXF(Y, W, M, L, I, or V) and
QXPF(Y, W, M, L, I, or V) favor deamidation of the Q
(Fig. 1 B). To verify these “patterns” for deamidation by
tTG, a large panel of gluten peptides was synthesized,
treated with tTG and analyzed by mass spectrometry (Table
I). Without exception we found that a Q preceding a P
was not deamidated by tTG while in the majority of cases a
P at Q
 
 
 
3 also inhibited deamidation. In contrast, a bulky/
hydrophobic residue at Q
 
 
 
3, and P at Q
 
 
 
2 allowed good
deamidation. In the case that two opposite rules coincide,
as is found in peptide 20 (LQQPQQ
 
6
 
PQFQPQQQF), the
negative effect of QP
 
↓
 
 overruled the positive effect of
QXXF
 
↑
 
 at position Q
 
6
 
. Together, these results confirmed
the defined patterns. Proline thus plays a crucial role in the
deamidation of gluten peptides.
 
Prediction of Novel Gluten Epitopes.
 
The peptide-binding
motifs of the disease-associated molecules HLA-DQ2 and
HLA-DQ8 display preferential binding of negative charges
at anchor positions (8–10). HLA-DQ2 has a strong prefer-
ence for a negative charge at p4 and p7 (8, 9). Strikingly,
at p6 a proline is one of the preferred amino acids in the
HLA-DQ2 peptide binding motif that could thus target
specific deamidation at p4 (Table II). Therefore, we com-
bined the HLA-DQ2 peptide-binding motif with the
specificity of tTG to construct a search algorithm that
could be used to predict T cell stimulatory gluten peptides
from the gluten database (Table II). In this algorithm
glutamine residues were introduced at the putative DQ2
binding positions p4 and p7. These serve as potential tar-
get sites for tTG to allow introduction of a negative charge
at these positions. Next, proline was selected for p6 to 
645
 
Vader et al. Brief Definitive Report
 
promote deamidation at Q
 
4
 
, which is also consistent with
the requirements for peptide binding at this position (Ta-
ble II). For the p9 position two options were designed. In
the first option bulky/hydrophobic residues were selected
for p9, according to the peptide-binding motif. In the sec-
ond option, a proline residue was placed at p9, followed
by bulky/hydrophobic at p10. This option does not agree
with the peptide-binding motif but should allow optimal
deamidation at Q
 
7
 
 according to our QXPF pattern. The
remaining positions p1, p2, p3, p5, and p8 were not de-
fined (Table II). These two algorithms were used to search
in the gluten database. A total of 98 matches were ob-
tained, which corresponded to 27 unique gluten se-
quences. 13 of these were predicted by algorithm 1, the
others by algorithm 2. These 27 peptides were synthesized
and deamidated by tTG. Subsequent mass spectral analysis
confirmed deamidation of the predicted Q
 
4
 
 and Q
 
7
 
 resi-
dues (data not shown). The native and deamidated pep-
tides were pooled in pools of five peptides each and tested
in T cell proliferation assays with three gluten-specific T
cell lines isolated from small intestinal biopsies of CD pa-
tients. Two of these T cell lines responded to stimulation
by several of the deamidated peptide pools (Fig. 2 A, re-
sults shown for one of the T cell lines). Strong T cell re-
sponses were only found against pools that contained pep-
tides predicted by the second algorithm, X X X Q
 
4
 
 X P
 
6
 
Q
 
7
 
 X P
 
9
 
 (Y, F, W, I, L)
 
10
 
 (Fig. 2 A and B). Subsequently,
the T cell line was tested against the individual peptides of
the positive pools, and found to respond to eight out of 13
peptides tested (Fig. 2 B).
In addition we performed searches with a less strict vari-
ant of algorithm 2, X X X X
 
4
 
 X P
 
6
 
 Q
 
7
 
 X P
 
9
 
 (Y,F,W,I,L)
 
10
 
,
which predicts the deamidation of only one Q residue.
This search yielded 261 matches in the gluten database (Ta-
ble III). 18 of these matches corresponded to a known T
cell stimulatory 
 
 
 
-gliadin peptide (sequence QLQPF-
PQPQLPY) (11, 12).
 
Presence of T Cell Stimulatory Sequences in Rye, Barley, and
Oats.
 
Next we used the three algorithms to perform data-
base searches in the gluten-like hordeins from barley, seca-
lins from rye, and avenins from oats. While the first two
cereals are toxic for CD patients, the latter is not (15, 16).
Strikingly, all three search algorithms yielded many
matches in the available hordein and secalin sequences but
none in the avenin sequences (Table III). Consequently,
the predicted T cell stimulatory gluten peptide QQPF-
PQQPQQPFPQ (Fig. 2) is present in hordeins and secalins
but not in avenins (Table III). Additional database searches
Figure 1. The influence of amino acid substitutions on deamidation of Q208
and Q216 in an HLA-DQ8–restricted gliadin peptide. (A) Overview of the influ-
ence of COOH-terminal amino acid substitutions on deamidation of Q208 in the
short version of the gliadin peptide and Q216 in the long version of the peptide.
aThe amino acids G209, S210, F211, N217, and Q219 were substituted for all amino ac-
ids except lysine and cysteine, because these residues could affect deamidation by
formation of disulphide bridges and tTG driven cross-linking, respectively. The
effect on deamidation was determined by mass spectrometry. Substitutions that re-
sulted in major differences in deamidation are designated with arrows: ↓↓ decrease
of 70–100%; ↓ decrease of 30–69%. Dash indicates no effect of the substitution;
substitution at other positions in the peptide had only minor effects on deamida-
tion of the Q208 and Q216 residues (data not shown). (B) Patterns for deamidation
in the HLA-DQ8–restricted gliadin peptide. X stands for any amino acid. 
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with less strict algorithms revealed a general lack of matches
in the avenin database as compared with the gluten, hor-
dein, and secalin databases (Table III). Notably, no matches
were found in the avenins with three variants of the predic-
tive algorithm 2.
 
Discussion
 
We have investigated the deamidation patterns of gluten
peptides by tTG. The results demonstrate clear and selec-
tive deamidation patterns that to a large extent can be ex-
plained by strong effects of the spacing between the target
 
Table II.
 
Design of Search Algorithms Based on the HLA-DQ2 Peptide-binding Motif and the tTG Specificity
 
DQ2 peptide-binding motif
Residue 1 2 3 4 5 6 7 89 1 0
Preferred F, W, Y, I, L, V D, E, V, L, I P, A, E D, E F, W, Y, I, L, V, M -
DQ2 epitope search algorithms
Algorithm 1 X
 
X X Q X P Q X F, Y, W, I, L
 
X
Algorithm 2 X
 
X X Q X P Q X P F, Y, W, I, L
 
X stands for any amino acid.
 
Table I.
 
Validation of the Deamidation Patterns
 
Pattern
Peptides QP 
 
↓
 
QXXF 
 
↑
 
QXXP 
 
↓
 
QXP 
 
↑
 
1 VPVPQLQPQNPSQ
 
Q
 
QPQE
 
Q
 
VPL
 
100% 100% 100% 66%
 
2 PLVQ
 
QQ
 
QFLGQ
 
Q
 
QPFPPQ
 
100% 100% 100% 100%
 
3 YYPTSP
 
Q
 
QSGQG - - - -
4 QG
 
Q
 
QGYYPTSPQ -
 
50%
 
--
5 SS
 
Q
 
VSFQPSQLN
 
100% 100%
 
--
6 FPQT
 
Q
 
QPQQLFPQSQ
 
100%
 
0%
 
100% 100%
 
7 G
 
Q
 
QGYYPTSVQ
 
Q
 
SGQ -
 
50%
 
--
8 GSVQP
 
Q
 
Q
 
Q
 
LPQFEIR
 
100% 100% 100% 100%
 
9 FPQHCNYQ
 
Q
 
QPQTFPQPF
 
100%
 
-
 
100% 100%
 
10 QQPIQPQ
 
Q
 
FP
 
Q
 
QQFF
 
100% 50% 100% 50%
 
11 QSG
 
Q
 
YQ
 
Q
 
QPQMQTT
 
100%
 
-
 
100% 100%
 
12 ESQ
 
Q
 
S
 
Q
 
QDEPQPF 
 
100%
 
-
 
100%
 
-
13 FPQPEDQ
 
Q
 
SQQSE 
 
100%
 
-- -
14 LQQVQ
 
Q
 
GP
 
QQ
 
QPFPQPQPF
 
100% 100% 66% 100%
 
15 QVQWPQQQPFPQP
 
Q
 
QPF
 
100% 50% 100% 33%
 
16 PLLP
 
Q
 
QPFPSQQEQPQF
 
100% 50%
 
a
 
100% 100%
 
17 WQ
 
Q
 
QPPFSQEQPIL
 
100%
 
0%
 
a
 
33% 100%
 
18 QSNLPQPA
 
Q
 
QPFQPQVPQQP
 
100% 100%
 
-
 
66%
 
19 WFQPSQLNP
 
Q
 
A
 
Q
 
QDQPQ
 
100%
 
-
 
100%
 
-
20 LQQP
 
Q
 
QPQFQP
 
Q
 
QQF
 
100% 50%
 
a
 
100% 50%
 
21 VQQ
 
Q
 
IPVVQPSIL
 
100% 33%
 
a
 
100% 100%
 
The observed deamidation patterns in a set of 21 gluten peptides were compared with those predicted according to the deamidation patterns given
in Fig. 1. The deamidation patterns are represented in the 4 columns. The percentages shown indicate whether the pattern is fully or partially
applicable to the specific deamidation of Q residues in the listed gluten peptides. A bar (-) indicates the absence of that sequence in the peptide.
Deamidated glutamine residues are shown in bold and underlined.
 
a
 
QP inhibition of deamidation overrules the positive influence of QXXF. 
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Figure 2. Stimulation of gluten-specific T cell lines by
predicted peptides. (A) A gluten-specific T cell line iso-
lated from a small intestinal biopsy of a CD patient was
tested against gluten, tTG-treated gluten, and against the
predicted peptides that were present in pools of five pep-
tides each (pools 1–14). The odd numbers represent pools
that contain the native peptides, whereas the even numbers
represent corresponding pools that were treated with tTG.
Strong reactivity of the T cell line was only observed with
tTG-treated gluten and tTG-treated pools of peptides pre-
dicted by the XXXQXPQXPY algorithm. Cpm indicates
3[H]thymidine incorporation. (B) Reactivity of the T cell
line against the individual peptides from the T cell stimula-
tory pools. Bars indicated with an asterisk are considered
positive (Stimulation Index   3).
 
Table III.
 
Database Searches with the Search Algorithms
 
Number of matches
in databases
Search algorithm Gluten Hordein Secalin Avenin
Algorithm 1 Q
 
4
 
XPQ
 
7
 
X(YFWIL) 52 48 8 -
Algorithm 1 – Q
 
4
 
XXPQ7X(YFWIL) 334 91 14 6
Algorithm 1 – Q
 
7
 
Q
 
4
 
XPXX(YFWIL) 286 142 60 11
Algorithm 2 Q
 
4
 
XPQ
 
7
 
XP(YFWIL) 46 60 33 -
Algorithm 2 – Q
 
4
a
 
XXPQ
 
7
 
XP(YFWIL) 262 196 89 -
Algorithm 2 – Q
 
7
 
Q
 
4
 
XPXXP(YFWIL) 51 68 33 -
Short algorithm QXP(YFWIL) X 
 
≠ Pb  500 276 105 7
Predicted epitope QQPFPQQPQQPFPQ 6 12 2 -
The search algorithms reveal many matches in the gluten, hordeins, and secalin sequences but very few in the avenin sequences. The predictive
algorithm 2 (QXPQXP[YFWIL]) and the less strict variants of that algorithm have no matches in the avenin database. The novel T cells stimulatory
gluten peptide (QQPFPQQPQQPFPQ) is also found in the hordeins and secalin but not in the avenins. X stands for any amino acid.
aAlgorithm 2 without the specification of a Q at position 4 predicts the known gliadin  9 epitope.
bA proline at p2 in this algorithm inhibits deamidation of the glutamine.648 Cereal Toxicity in Celiac Disease
glutamine residue and COOH-terminal proline residues. It
has been described previously that a glutamine between
proline residues is not modified by tTG (17). An important
general role for proline in guiding tTG specificity, how-
ever, has not been appreciated. Proline, after glutamine, is
the second most abundant amino acid in gluten (18) and
thus the dominant factor in the selective deamidation of
gluten peptides observed. In addition, the presence of a
large hydrophobic amino acid three positions COOH ter-
minally from the target glutamine has a strong positive in-
fluence on deamidation. This is highly significant since the
sequence QXPF(Y) is one of the most frequently found se-
quences in gluten molecules and is predicted to be invari-
ably deamidated by tTG. Moreover, cleavage by the en-
zyme pepsin is known to occur after phenylalanine and to
a lesser extent after tyrosine, leucine, and isoleucine, and
will thus generate many gluten peptides with the tTG sub-
strate sequence QXPF(Y) at the COOH terminus. The se-
quential activity of pepsin and tTG, therefore, favors the
generation of gluten peptides with an appropriate p7 an-
chor for binding to HLA-DQ2. We also demonstrate that
by combining the HLA-DQ2 peptide-binding motif with
two deamidation patterns an algorithm is obtained that
predicts novel T cell stimulatory peptides in gluten. Strik-
ingly, in this predictive algorithm (X X X Q4 X P6 Q7 X
P9 [Y,F,W,I,L]10) we had incorporated a deamidation pat-
tern that results in peptides that do not optimally fit the
HLA-DQ2 peptide-binding motif, e.g., they lack an
amino acid with a large hydrophobic side chain at position
9 in the peptide. The lack of this anchor is probably com-
pensated for by the introduction of two negative charged
anchor residues in the peptide at p4 and p7 as the result of
deamidation. Thus, the T cell stimulatory activity of these
peptides appears to depend more on optimal deamidation
than on strict adherence to the exact HLA-DQ2 peptide-
binding motif.
A less stringent search algorithm, combining only one
deamidation rule with the HLA-DQ2 peptide-binding
motif, proved equally successful since it predicted a previ-
ously identified T cell stimulatory  -gliadin peptide (11,
12). Importantly, the first predictive algorithm identified 13
peptides, eight out of which stimulated T cells. The sec-
ond, less stringent algorithm predicted 261 peptides. 18 of
those (1 in 15) matched a known T cell stimulatory gliadin
peptide. These algorithms, therefore, have a high predic-
tive value. Therefore, it is striking that these algorithms
identified very similar and sometimes identical peptides in
the barley- and rye-derived hordeins and secalins but not in
the oats-derived avenins. Oats is considered safe for CD
patients (15, 16). While gliadins, hordeins, and secalins
contain  36% glutamine and 20% proline, avenins contain
a similar percentage of glutamine (34%) but half the
amount of proline (10%) (18). Deamidation of avenins is
thus likely to occur in a much more random fashion. In-
deed, the lack of proline residues in Q-rich regions leads to
nonselective deamidation of the glutamine residues in such
regions (data not shown). Collectively, our results indicate
that due to nonselective deamidation no T cell stimulatory
neoepitopes can be generated from the avenins and thus of-
fer an explanation for the clinical observation that oats is
not toxic for CD patients. Moreover, our results indicate
that the replacement of particular proline residues in gluten
by other amino acids would yield gluten molecules with
considerably less toxicity for CD patients but that would
retain many of the chemical and physical properties desired
in gluten.
tTG is a ubiquitous enzyme and could thus be involved
in the modification of proteins at other sites in the body.
Therefore, it will be of interest to investigate if the defined
deamidation patterns and search algorithms can be used to
identify novel T cell stimulatory peptides that are relevant
for autoimmune diseases.
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